Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 5.99
(2.92%)
CNY 5.99
(2.92%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 890.71 Million CNY | 16.3% |
| 2022 | 765.88 Million CNY | -9.25% |
| 2021 | 843.9 Million CNY | 2.0% |
| 2020 | 827.33 Million CNY | 1.0% |
| 2019 | 819.11 Million CNY | 34.71% |
| 2018 | 608.05 Million CNY | 16.37% |
| 2017 | 522.53 Million CNY | 4.75% |
| 2016 | 498.86 Million CNY | 1.51% |
| 2015 | 491.43 Million CNY | 11.69% |
| 2014 | 439.98 Million CNY | 32.68% |
| 2013 | 331.61 Million CNY | 21.04% |
| 2012 | 273.97 Million CNY | 39.29% |
| 2011 | 196.7 Million CNY | 8.05% |
| 2010 | 182.05 Million CNY | -16.03% |
| 2009 | 216.81 Million CNY | 22.34% |
| 2008 | 177.22 Million CNY | -23.64% |
| 2007 | 232.09 Million CNY | 84.6% |
| 2006 | 125.72 Million CNY | 49.78% |
| 2005 | 83.94 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 262.94 Million CNY | 26.72% |
| 2024 Q3 | 255.78 Million CNY | -2.72% |
| 2024 Q1 | 207.5 Million CNY | -13.86% |
| 2023 Q3 | 211.78 Million CNY | -15.28% |
| 2023 Q4 | 240.89 Million CNY | 13.74% |
| 2023 FY | 890.71 Million CNY | 16.3% |
| 2023 Q1 | 188.03 Million CNY | -9.85% |
| 2023 Q2 | 249.99 Million CNY | 32.95% |
| 2022 Q3 | 206.04 Million CNY | 23.13% |
| 2022 FY | 765.88 Million CNY | -9.25% |
| 2022 Q2 | 167.33 Million CNY | -9.02% |
| 2022 Q4 | 208.57 Million CNY | 1.23% |
| 2022 Q1 | 183.93 Million CNY | 12.8% |
| 2021 Q2 | 313.19 Million CNY | 41.03% |
| 2021 Q1 | 222.07 Million CNY | 8.98% |
| 2021 Q4 | 163.06 Million CNY | 12.03% |
| 2021 Q3 | 145.56 Million CNY | -53.52% |
| 2021 FY | 843.9 Million CNY | 2.0% |
| 2020 FY | 827.33 Million CNY | 1.0% |
| 2020 Q2 | 241.83 Million CNY | 92.27% |
| 2020 Q3 | 255.93 Million CNY | 5.83% |
| 2020 Q4 | 203.78 Million CNY | -20.38% |
| 2020 Q1 | 125.78 Million CNY | -40.53% |
| 2019 Q2 | 229 Million CNY | 32.76% |
| 2019 FY | 819.11 Million CNY | 34.71% |
| 2019 Q4 | 211.5 Million CNY | 2.62% |
| 2019 Q3 | 206.11 Million CNY | -10.0% |
| 2019 Q1 | 172.49 Million CNY | 19.78% |
| 2018 FY | 608.05 Million CNY | 16.37% |
| 2018 Q3 | 152.82 Million CNY | -19.33% |
| 2018 Q1 | 121.78 Million CNY | 16.75% |
| 2018 Q4 | 144.01 Million CNY | -5.77% |
| 2018 Q2 | 189.43 Million CNY | 55.55% |
| 2017 Q4 | 104.3 Million CNY | -23.21% |
| 2017 FY | 522.53 Million CNY | 4.75% |
| 2017 Q2 | 166.66 Million CNY | 44.02% |
| 2017 Q1 | 115.72 Million CNY | 24.34% |
| 2017 Q3 | 135.83 Million CNY | -18.5% |
| 2016 Q1 | 115.47 Million CNY | 22.3% |
| 2016 Q3 | 134.29 Million CNY | -13.93% |
| 2016 Q2 | 156.02 Million CNY | 35.12% |
| 2016 Q4 | 93.07 Million CNY | -30.69% |
| 2016 FY | 498.86 Million CNY | 1.51% |
| 2015 Q3 | 125.23 Million CNY | -19.63% |
| 2015 FY | 491.43 Million CNY | 11.69% |
| 2015 Q2 | 155.82 Million CNY | 34.4% |
| 2015 Q4 | 94.41 Million CNY | -24.6% |
| 2015 Q1 | 115.94 Million CNY | -23.88% |
| 2014 Q4 | 152.31 Million CNY | 46.51% |
| 2014 Q1 | 78.57 Million CNY | -18.05% |
| 2014 Q2 | 105.12 Million CNY | 33.8% |
| 2014 FY | 439.98 Million CNY | 32.68% |
| 2014 Q3 | 103.96 Million CNY | -1.11% |
| 2013 FY | 331.61 Million CNY | 21.04% |
| 2013 Q4 | 95.87 Million CNY | 16.31% |
| 2013 Q1 | 68.25 Million CNY | -5.37% |
| 2013 Q2 | 85.06 Million CNY | 24.63% |
| 2013 Q3 | 82.42 Million CNY | -3.1% |
| 2012 Q3 | 74.96 Million CNY | 3.48% |
| 2012 FY | 273.97 Million CNY | 39.29% |
| 2012 Q4 | 72.12 Million CNY | -3.79% |
| 2012 Q2 | 72.44 Million CNY | 33.05% |
| 2012 Q1 | 54.44 Million CNY | -0.88% |
| 2011 Q3 | 53.05 Million CNY | 5.52% |
| 2011 Q2 | 50.27 Million CNY | 30.81% |
| 2011 FY | 196.7 Million CNY | 8.05% |
| 2011 Q1 | 38.43 Million CNY | 7.53% |
| 2011 Q4 | 54.93 Million CNY | 3.54% |
| 2010 Q1 | 62.05 Million CNY | 34.98% |
| 2010 Q2 | 46.82 Million CNY | -24.54% |
| 2010 Q3 | 37.42 Million CNY | -20.08% |
| 2010 FY | 182.05 Million CNY | -16.03% |
| 2010 Q4 | 35.74 Million CNY | -4.49% |
| 2009 Q4 | 45.97 Million CNY | -13.91% |
| 2009 Q2 | 65.96 Million CNY | 28.14% |
| 2009 Q1 | 51.47 Million CNY | -6.78% |
| 2009 FY | 216.81 Million CNY | 22.34% |
| 2009 Q3 | 53.39 Million CNY | -19.05% |
| 2008 Q3 | 43.45 Million CNY | 0.0% |
| 2008 Q4 | 55.22 Million CNY | 27.09% |
| 2008 FY | 177.22 Million CNY | -23.64% |
| 2007 FY | 232.09 Million CNY | 84.6% |
| 2006 FY | 125.72 Million CNY | 49.78% |
| 2005 FY | 83.94 Million CNY | 0.0% |